135 related articles for article (PubMed ID: 8422647)
1. Transforming growth factor-beta 2 is an autocrine growth inhibitory factor for the MOSER human colon carcinoma cell line.
Levine AE; Lewis LR
Cancer Lett; 1993 Jan; 68(1):33-41. PubMed ID: 8422647
[TBL] [Abstract][Full Text] [Related]
2. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
Levine AE; Black B; Brattain MG
J Cell Physiol; 1989 Mar; 138(3):459-66. PubMed ID: 2925796
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Levine AE; Brattain MG
Cancer Res; 1987 Jun; 47(11):2950-4. PubMed ID: 3471320
[TBL] [Abstract][Full Text] [Related]
4. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
Zipfel PA; Ziober BL; Morris SL; Mulder KM
Cell Growth Differ; 1993 Aug; 4(8):637-45. PubMed ID: 8398905
[TBL] [Abstract][Full Text] [Related]
5. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Jan Y; Brattain MG; Tobon A; Varani J
Cancer Res; 1989 Apr; 49(8):2112-7. PubMed ID: 2539253
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
Hafez MM; Infante D; Winawer S; Friedman E
Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
[TBL] [Abstract][Full Text] [Related]
7. Alterations in c-myc expression in relation to maturational status of human colon carcinoma cells.
Mulder KM; Brattain MG
Int J Cancer; 1988 Jul; 42(1):64-70. PubMed ID: 3164710
[TBL] [Abstract][Full Text] [Related]
8. TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.
Jennings MT; Kaariainen IT; Gold L; Maciunas RJ; Commers PA
Hum Pathol; 1994 May; 25(5):464-75. PubMed ID: 8200640
[TBL] [Abstract][Full Text] [Related]
9. N,N-dimethylformamide-induced synthesis of an anti-fibronectin reactive protein in cultured human colon carcinoma cells.
Marks ME; Ziober BL; Brattain MG
Cancer Res; 1986 Oct; 46(10):5248-58. PubMed ID: 3756877
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line.
Hoosein NM; Brattain DE; McKnight MK; Childress KE; Chakrabarty S; Brattain MG
Cancer Lett; 1988 Jun; 40(2):219-32. PubMed ID: 3164250
[TBL] [Abstract][Full Text] [Related]
11. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
Hsu S; Huang F; Hafez M; Winawer S; Friedman E
Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
[TBL] [Abstract][Full Text] [Related]
12. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
Mulder KM; Ramey MK; Hoosein NM; Levine AE; Hinshaw XH; Brattain DE; Brattain MG
Cancer Res; 1988 Dec; 48(24 Pt 1):7120-5. PubMed ID: 3191488
[TBL] [Abstract][Full Text] [Related]
13. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
[TBL] [Abstract][Full Text] [Related]
14. Modulation of a high molecular weight form of transforming growth factor-alpha in human colon carcinoma cell lines.
Watkins LF; Brattain MG; Levine AE
Cancer Lett; 1988 May; 40(1):59-70. PubMed ID: 3259465
[TBL] [Abstract][Full Text] [Related]
15. Induction of carcinoembryonic antigen secretion and modulation of protein secretion/expression and fibronectin/laminin expression in human colon carcinoma cells by transforming growth factor-beta.
Chakrabarty S; Tobon A; Varani J; Brattain MG
Cancer Res; 1988 Jul; 48(14):4059-64. PubMed ID: 3289738
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.
Wu SP; Theodorescu D; Kerbel RS; Willson JK; Mulder KM; Humphrey LE; Brattain MG
J Cell Biol; 1992 Jan; 116(1):187-96. PubMed ID: 1730743
[TBL] [Abstract][Full Text] [Related]
17. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
Sun L; Wu S; Coleman K; Fields KC; Humphrey LE; Brattain MG
Exp Cell Res; 1994 Sep; 214(1):215-24. PubMed ID: 8082724
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor beta 1 (TGF beta 1) is an autocrine positive regulator of colon carcinoma U9 cells in vivo as shown by transfection of a TGF beta 1 antisense expression plasmid.
Huang F; Newman E; Theodorescu D; Kerbel RS; Friedman E
Cell Growth Differ; 1995 Dec; 6(12):1635-42. PubMed ID: 9019169
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human colon-carcinoma cell adhesion to extracellular matrix by transforming growth factor beta 1.
Chakrabarty S
Int J Cancer; 1992 Apr; 50(6):968-73. PubMed ID: 1555895
[TBL] [Abstract][Full Text] [Related]
20. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
Wu SP; Sun LZ; Willson JK; Humphrey L; Kerbel R; Brattain MG
Cell Growth Differ; 1993 Feb; 4(2):115-23. PubMed ID: 8494782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
